Alanine transaminase: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
Line 1: Line 1:
{{protein
{{Infobox protein
| Name = glutamic-pyruvate transaminase
| Name = glutamic-pyruvate transaminase1
| caption =  
| caption =
| image =  
| image =
| width =  
| width =
| HGNCid = 4552
| HGNCid = 4552
| Symbol = GPT
| Symbol = GPT
| AltSymbols =  
| AltSymbols =
| EntrezGene = 2875
| EntrezGene = 2875
| OMIM = 138200
| OMIM = 138200
| RefSeq = NM_005309
| RefSeq = NM_005309
| UniProt = P24298
| UniProt = P24298
| PDB =  
| PDB =
| ECnumber = 2.6.1.2
| ECnumber = 2.6.1.2
| Chromosome = 8
| Chromosome = 8
Line 18: Line 18:
| LocusSupplementaryData = -qter
| LocusSupplementaryData = -qter
}}
}}
{{SI}}
{{Infobox enzyme
{{CMG}}
| Name = Alanine transaminase
| EC_number = 2.6.1.2
| CAS_number = 9000-86-6
| IUBMB_EC_number = 2/6/1/2
| GO_code = 0004021
| image =
| width =
| caption =
}}


'''Alanine transaminase''' ('''ALT''') is a [[transaminase]] [[enzyme]] ({{EC number|2.6.1.2}}).  It is also called '''alanine aminotransferase''' ('''ALAT''') and was formerly called serum glutamate-pyruvate transaminase (SGPT) or serum glutamic-pyruvic transaminase (SGPT) and was first characterized in the mid-1950s by Arthur Karmen and colleagues.<ref>{{cite journal | vauthors = Karmen A, Wroblewski F, Ladue JS | title = Transaminase activity in human blood | journal = The Journal of Clinical Investigation | volume = 34 | issue = 1 | pages = 126–31 | date = Jan 1955 | pmid = 13221663 | doi = 10.1172/JCI103055 | pmc=438594}}</ref> ALT is found in [[blood plasma|plasma]] and in various body tissues, but is most common in the [[liver]]. It catalyzes the two parts of the [[alanine cycle]]. Serum ALT level, serum AST ([[aspartate transaminase]]) level, and their ratio ([[AST/ALT ratio]]) are commonly measured clinically as [[biomarker]]s for liver health. The tests are part of [[blood test|blood panels]].


== Function ==
ALT catalyzes the transfer of an [[amino]] group from [[alanine|L-alanine]] to [[Alpha-Ketoglutaric acid|α-ketoglutarate]], the products of this reversible [[transamination]] reaction being [[pyruvate]] and [[glutamate|L-glutamate]].


==Overview==
:[[glutamate|L-glutamate]] + [[pyruvate]] &#8652;  [[alpha-ketoglutaric acid|α-ketoglutarate]] + [[alanine|L-alanine]]
[[Image:Alanine amino transférase.png|thumb|none|600px|Alanine transaminase]]


'''Alanine transaminase''' or '''ALT''' is a [[transaminase]] [[enzyme]] ({{EC number|2.6.1.2}}). It is also known as '''SGPT'''
ALT (and all aminotransferases) require the coenzyme [[pyridoxal phosphate]], which is converted into pyridoxamine in the first phase of the reaction, when an amino acid is converted into a keto acid.


'''ALT''' is found in [[blood plasma|serum]] and in various bodily tissues, but is most commonly associated with the [[liver]];
==Clinical significance==
ALT is commonly measured clinically as a part of a diagnostic evaluation of [[Liver function tests|hepatocellular injury]], to determine liver health.  When used in diagnostics, it is almost always measured in international units/liter (IU/L)<ref name=Wang2012>{{cite journal | vauthors = Wang CS, Chang TT, Yao WJ, Wang ST, Chou P | title = Impact of increasing alanine aminotransferase levels within normal range on incident diabetes | journal = Journal of the Formosan Medical Association = Taiwan Yi Zhi | volume = 111 | issue = 4 | pages = 201–8 | date = April 2012 | pmid = 22526208 | doi = 10.1016/j.jfma.2011.04.004 }}</ref><ref name=Ghouri2010>{{cite journal | vauthors = Ghouri N, Preiss D, Sattar N | title = Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data | journal = Hepatology | volume = 52 | issue = 3 | pages = 1156–61 | date = September 2010 | pmid = 20658466 | doi = 10.1002/hep.23789 }}</ref> or µkat.  While sources vary on specific reference range values for patients, 10-40 IU/L is the standard reference range for experimental studies.<ref name=Wang2012 /> Alanine transaminase shows a marked [[diurnal variation]].{{citation needed|date=June 2013}}


==Function==
The [[AST/ALT ratio|ratio of ALT to AST (aspartate aminotransferase)]] also has clinical significance.
It catalyzes the transfer of an [[amino]] group from [[alanine]] to [[Ketoglutaric acid|a-ketoglutarate]], the products of this reversible [[ transamination]] reaction being [[pyruvate]] and [[glutamate]].


:[[glutamate]] + [[pyruvate]] {{unicode|&#8652;}}  [[alpha-ketoglutaric acid|α-ketoglutarate]] + [[alanine]]
===Elevated levels===
Test results should always be interpreted using the [[reference range]] from the laboratory that produced the result. However typical reference intervals for ALT are:
{| class="wikitable"
|-
|'''Patient type'''||Reference ranges<ref>{{cite web|title=Alanine aminotransferase: analyte monograph|url=http://www.acb.org.uk/Nat%20Lab%20Med%20Hbk/ALT.pdf|work=Association for Clinical Biochemistry and Laboratory Medicine|accessdate=7 October 2013}}</ref>  
|-
| Female ||  ≤ 34 IU/L
|-
| Male ||  ≤ 52 IU/L
|}


[[Image:Alanine amino transférase.png|thumb|center|600px|Alanine transaminase]]
Significantly elevated levels of ALT (SGPT) often suggest the existence of other medical problems such as viral [[hepatitis]], [[diabetes]], [[congestive heart failure]], liver damage, [[bile duct]] problems, [[infectious mononucleosis]], or [[myopathy]], so ALT is commonly used as a way of screening for liver problems. Elevated ALT may also be caused by dietary [[choline]] deficiency.  However, elevated levels of ALT do not automatically mean that medical problems exist.  Fluctuation of ALT levels is normal over the course of the day, and they can also increase in response to strenuous physical exercise.<ref>Paul T. Giboney M.D., [http://www.aafp.org/afp/20050315/1105.html Mildly Elevated Liver Transaminase Levels in the Asymptomatic Patient], ''American Family Physician''.</ref>


==Clinical significance==
When elevated ALT levels are found in the blood, the possible underlying causes can be further narrowed down by measuring other enzymes.  For example, elevated ALT levels due to [[hepatocyte]] damage can be distinguished from bile duct problems by measuring [[alkaline phosphatase]].  Also, myopathy-related elevations in ALT should be suspected when the aspartate transaminase (AST) is greater than ALT; the possibility of muscle disease causing elevations in liver tests can be further explored by measuring muscle enzymes, including [[creatine kinase]]. Many drugs may elevate ALT levels, including [[Zileuton]], omega-3-acid ethyl esters ([[Lovaza]]),<ref>{{cite journal | pmc = 2683599 | title = Omega-3-acid Ethyl Esters (Lovaza) For Severe Hypertriglyceridemia | journal = Pharmacy and Therapeutics | date = 2008 | volume = 33 | issue = 5 | pages = 271–303 | vauthors = Koski RR }}</ref> anti-inflammatory drugs, antibiotics, cholesterol medications, some antipsychotics  such as risperidone, and anticonvulsants.{{Citation needed|date=August 2011}}.  [[Paracetamol]] (also known as acetaminophen) may also elevate ALT levels.<ref name="pmid16820551">{{cite journal | vauthors = Watkins PB, Kaplowitz N, Slattery JT, Colonese CR, Colucci SV, Stewart PW, Harris SC | title = Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial | journal = JAMA | volume = 296 | issue = 1 | pages = 87–93 | date = July 2006 | pmid = 16820551 | doi = 10.1001/jama.296.1.87 }}</ref>
It is commonly measured clinically as a part of a diagnostic [[liver function test]], to determine liver health.  It is also called '''serum glutamate pyruvate transaminase''' ('''SGPT''') or '''alanine aminotransferase''' ('''ALAT'''). Diagnostically, it is almost always measured in units/litre (U/L).
 
===Elevated levels===
Elevated levels of '''ALT''' often suggest the existence of other medical problems such as alcoholic or viral [[hepatitis]], [[congestive heart failure]], [[liver]] damage, [[biliary duct]] problems, infectious [[mononucleosis]], or [[myopathy]].  For this reason, '''ALT''' is commonly used as a way of screening for liver problems.  However, elevated levels of '''ALT''' do not automatically mean that medical problems exist.  Fluctuation of '''ALT''' levels is normal over the course of the day, and '''ALT''' levels can also increase in response to strenuous physical exercise <ref>Paul T. Giboney M.D., [http://www.aafp.org/afp/20050315/1105.html Mildly Elevated Liver Transaminase Levels in the Asymptomatic Patient], ''American Family Physician''.</ref>.
 
When elevated ALT levels are found in the blood, the possible underlying causes can be further narrowed down by measuring other enzymes.  For example, elevated ALT levels due to [[hepatocyte|liver-cell]] damage can be distinguished from [[biliary duct]] problems by measuring [[alkaline phosphatase]].  Also, [[myopathy]]-related ALT levels can be ruled out by measuring [[creatine kinase]] enzymes.


For years, the [[American Red Cross]] used '''ALT''' testing as part of the battery of tests to ensure the safety of its blood supply by deferring donors with elevated '''ALT''' levels.  The intent was to identify donors potentially infected with [[Hepatitis C]] ("non-A non-B [[Hepatitis]]") because there was no specific test for that disease at the time.  With the introduction of second generation [[ELISA]] antibody tests for [[Hepatitis C]], the Red Cross changed the '''ALT''' policy.  As of July 2003, donors previously disqualified for elevated '''ALT''' levels and no other reason may be reinstated as donors by contacting the donor counseling department of their regional Red Cross organization<ref>[http://www.tompkins-redcross.org/donor_req.htm Red Cross Donor Requirements]</ref>.
For years, the [[American Red Cross]] used ALT testing as part of the battery of tests to ensure the safety of its blood supply by deferring donors with elevated ALT levels.  The intent was to identify donors potentially infected with hepatitis C because no specific test for that disease was available at the time.  Prior to July 1992, widespread blood donation testing in the USA for hepatitis C was not carried out by major blood banks.  With the introduction of second-generation [[ELISA]] antibody tests for [[hepatitis C]], the Red Cross changed the ALT policy.  {{As of|2003|07}}, donors previously disqualified for elevated ALT levels and no other reason may be reinstated as donors by contacting the donor-counseling department of their regional Red Cross organization.<ref>[http://www.tompkins-redcross.org/donor_req.htm Red Cross Donor Requirements]</ref>


==Differential Diagnosis of Elevated ALT==
In 2000, the American Association for Clinical Chemistry determined that the appropriate terminology for AST and ALT are aspartate aminotransferase and alanine aminotransferase. The term transaminase is outdated and no longer used in liver disease.<ref>Clin Chem 2000;46:2027-2049</ref>
* Acute [[hepatitis]]
* [[Alcoholic]] hepatopathy
* [[Asenapine maleate]]
* [[Cholangitis]]
* [[Cholestasis]]
* [[Chronic active hepatitis]]
* [[Cirrhosis]]
* [[Dermatomyositis]]
* [[Drugs]]
**[[Amoxicillin]]
**[[Anidulafungin]]
**[[Artemether and lumefantrin]]
**[[Asparaginase Erwinia Chrysanthemi]]
**[[Axitinib]]
**[[Aztreonam]]
**[[Bicalutamide]]
**[[Cefepime]]
**[[Cefprozil]]
**[[Ceftazidime]]
**[[Cefotaxime sodium]]
**[[Chenodiol]]
**[[Cladribine]]
**[[Crizotinib]]
**[[Deferiprone]]
**[[Doxorubicin Hydrochloride]]
**[[Eribulin]]
**[[Idelalisib]]
**[[Indinavir]]
**[[Interferon gamma]]
**[[Lacosamide]]
**[[Lamivudine]]
**[[Lincomycin Hydrochloride]]
**[[Meropenem]]
**[[Niacin]]
**[[Ritonavir]]
**[[Ruxolitinib]]
**[[Pertuzumab]]
**[[Pralidoxime]]
**[[Sorafenib]]
**[[Tigecycline]]
**[[Vedolizumab]]
* [[Epstein-Barr Virus]]
* [[Fatty liver]]
* [[Fulvestrant]]
* [[Hepatic tumor]]
* [[Hypothyroid]] myopathy
* [[Infliximab]]
* [[Malignant hyperthermia]]
* [[Malignancy]]
* [[Myocardial Infarction]]
* [[Myositis]]
* [[Open heart surgery]]
* [[Perimyocarditis]]
* [[Polymyositis]]
* [[Primary biliary cirrhosis]]
* Progressive myodystrophia
* [[Pulmonary Embolism]]
* [[Renal infarction]]
* [[Seizure]]
* Severe muscle [[trauma]]
* [[Spasm]]s, muscle injuries
* Strong physical work


==See also==
== See also ==
*[[Aspartate transaminase]]
*[[Liver function tests]]
*[[Liver function tests]]


==References==
== References ==
<references/>
{{reflist|33em}}


==External links==
== External links ==
* {{MeshName|Alanine+transaminase}}
* {{MeshName|Alanine+transaminase}}
* [http://www.acb.org.uk/Nat%20Lab%20Med%20Hbk/ALT.pdf ALT: analyte monograph; The Association for Clinical Biochemistry and Laboratory Medicine]
* [http://labtestsonline.org/understanding/analytes/alt/tab/test Alanine aminotransferase (ALT) at Lab Tests Online]


{{Glycolysis enzymes}}
{{Amino acid metabolism enzymes}}
{{Blood tests}}
{{Nitrogenous transferases}}
{{Enzymes}}
{{Glutamate metabolism and transport modulators}}
{{Portal bar|Molecular and Cellular Biology|border=no}}


{{Transaminases}}
{{Use dmy dates|date=April 2017}}
{{Glycolysis enzymes}}


[[Category:Chemical pathology]]
{{DEFAULTSORT:Alanine Transaminase}}
[[category:enzymes]]
[[Category:Biomarkers]]
[[Category:Liver function tests]]
[[Category:Enzymes]]
[[Category:EC 2.6.1]]
[[Category:EC 2.6.1]]
[[Category:Hepatology]]
[[Category:Hepatology]]
[[Category:Gastroenterology]]
[[Category:Glutamate (neurotransmitter)]]
 
[[de:Alanin-Aminotransferase]]
[[es:Alanina aminotransferasa]]
[[fr:Alanine amino transférase]]
[[nl:Alanineaminotransferase]]
[[ja:アラニンアミノ基転移酵素]]
[[pl:Aminotransferaza alaninowa]]
[[pt:Alanina aminotransferase]]
[[ru:Аланинаминотрансфераза]]
[[sv:Alaninaminotransferas]]
[[zh:谷丙转氨酶]]
 
{{WH}}
{{WS}}

Revision as of 08:27, 27 August 2017

glutamic-pyruvate transaminase1
Identifiers
SymbolGPT
Entrez2875
HUGO4552
OMIM138200
RefSeqNM_005309
UniProtP24298
Other data
EC number2.6.1.2
LocusChr. 8 q24.2-qter
Alanine transaminase
Identifiers
EC number2.6.1.2
CAS number9000-86-6
Databases
IntEnzIntEnz view
BRENDABRENDA entry
ExPASyNiceZyme view
KEGGKEGG entry
MetaCycmetabolic pathway
PRIAMprofile
PDB structuresRCSB PDB PDBe PDBsum
Gene OntologyAmiGO / QuickGO

Alanine transaminase (ALT) is a transaminase enzyme (EC 2.6.1.2). It is also called alanine aminotransferase (ALAT) and was formerly called serum glutamate-pyruvate transaminase (SGPT) or serum glutamic-pyruvic transaminase (SGPT) and was first characterized in the mid-1950s by Arthur Karmen and colleagues.[1] ALT is found in plasma and in various body tissues, but is most common in the liver. It catalyzes the two parts of the alanine cycle. Serum ALT level, serum AST (aspartate transaminase) level, and their ratio (AST/ALT ratio) are commonly measured clinically as biomarkers for liver health. The tests are part of blood panels.

Function

ALT catalyzes the transfer of an amino group from L-alanine to α-ketoglutarate, the products of this reversible transamination reaction being pyruvate and L-glutamate.

L-glutamate + pyruvate ⇌ α-ketoglutarate + L-alanine
Alanine transaminase

ALT (and all aminotransferases) require the coenzyme pyridoxal phosphate, which is converted into pyridoxamine in the first phase of the reaction, when an amino acid is converted into a keto acid.

Clinical significance

ALT is commonly measured clinically as a part of a diagnostic evaluation of hepatocellular injury, to determine liver health. When used in diagnostics, it is almost always measured in international units/liter (IU/L)[2][3] or µkat. While sources vary on specific reference range values for patients, 10-40 IU/L is the standard reference range for experimental studies.[2] Alanine transaminase shows a marked diurnal variation.[citation needed]

The ratio of ALT to AST (aspartate aminotransferase) also has clinical significance.

Elevated levels

Test results should always be interpreted using the reference range from the laboratory that produced the result. However typical reference intervals for ALT are:

Patient type Reference ranges[4]
Female ≤ 34 IU/L
Male ≤ 52 IU/L

Significantly elevated levels of ALT (SGPT) often suggest the existence of other medical problems such as viral hepatitis, diabetes, congestive heart failure, liver damage, bile duct problems, infectious mononucleosis, or myopathy, so ALT is commonly used as a way of screening for liver problems. Elevated ALT may also be caused by dietary choline deficiency. However, elevated levels of ALT do not automatically mean that medical problems exist. Fluctuation of ALT levels is normal over the course of the day, and they can also increase in response to strenuous physical exercise.[5]

When elevated ALT levels are found in the blood, the possible underlying causes can be further narrowed down by measuring other enzymes. For example, elevated ALT levels due to hepatocyte damage can be distinguished from bile duct problems by measuring alkaline phosphatase. Also, myopathy-related elevations in ALT should be suspected when the aspartate transaminase (AST) is greater than ALT; the possibility of muscle disease causing elevations in liver tests can be further explored by measuring muscle enzymes, including creatine kinase. Many drugs may elevate ALT levels, including Zileuton, omega-3-acid ethyl esters (Lovaza),[6] anti-inflammatory drugs, antibiotics, cholesterol medications, some antipsychotics such as risperidone, and anticonvulsants.[citation needed]. Paracetamol (also known as acetaminophen) may also elevate ALT levels.[7]

For years, the American Red Cross used ALT testing as part of the battery of tests to ensure the safety of its blood supply by deferring donors with elevated ALT levels. The intent was to identify donors potentially infected with hepatitis C because no specific test for that disease was available at the time. Prior to July 1992, widespread blood donation testing in the USA for hepatitis C was not carried out by major blood banks. With the introduction of second-generation ELISA antibody tests for hepatitis C, the Red Cross changed the ALT policy. As of July 2003, donors previously disqualified for elevated ALT levels and no other reason may be reinstated as donors by contacting the donor-counseling department of their regional Red Cross organization.[8]

In 2000, the American Association for Clinical Chemistry determined that the appropriate terminology for AST and ALT are aspartate aminotransferase and alanine aminotransferase. The term transaminase is outdated and no longer used in liver disease.[9]

See also

References

  1. ↑ Karmen A, Wroblewski F, Ladue JS (Jan 1955). "Transaminase activity in human blood". The Journal of Clinical Investigation. 34 (1): 126–31. doi:10.1172/JCI103055. PMC 438594. PMID 13221663.
  2. ↑ 2.0 2.1 Wang CS, Chang TT, Yao WJ, Wang ST, Chou P (April 2012). "Impact of increasing alanine aminotransferase levels within normal range on incident diabetes". Journal of the Formosan Medical Association = Taiwan Yi Zhi. 111 (4): 201–8. doi:10.1016/j.jfma.2011.04.004. PMID 22526208.
  3. ↑ Ghouri N, Preiss D, Sattar N (September 2010). "Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data". Hepatology. 52 (3): 1156–61. doi:10.1002/hep.23789. PMID 20658466.
  4. ↑ "Alanine aminotransferase: analyte monograph" (PDF). Association for Clinical Biochemistry and Laboratory Medicine. Retrieved 7 October 2013.
  5. ↑ Paul T. Giboney M.D., Mildly Elevated Liver Transaminase Levels in the Asymptomatic Patient, American Family Physician.
  6. ↑ Koski RR (2008). "Omega-3-acid Ethyl Esters (Lovaza) For Severe Hypertriglyceridemia". Pharmacy and Therapeutics. 33 (5): 271–303. PMC 2683599.
  7. ↑ Watkins PB, Kaplowitz N, Slattery JT, Colonese CR, Colucci SV, Stewart PW, Harris SC (July 2006). "Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial". JAMA. 296 (1): 87–93. doi:10.1001/jama.296.1.87. PMID 16820551.
  8. ↑ Red Cross Donor Requirements
  9. ↑ Clin Chem 2000;46:2027-2049

External links

Retrieved from "https://www.wikidoc.org/index.php?title=Alanine_transaminase&oldid=1422061"